Clinical Trial Update: A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

View source ↗

Summary

This is a long-term, 3-year follow-up update for patients who completed the KS-GIG-001-01 study in lumbosacral radiculopathy. The sponsor is Kolon Life Science.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radiculopathy

Drugs mentioned

• KS-GIG-001

Snippet

Sponsor: Kolon Life Science | Conditions: Lumbosacral Radiculopathy | Status: ACTIVE_NOT_RECRUITING